Pfizer Inc. sell Royal Bank of Canada
Start price
20.04.26
/
50%
€23.49
Target price
20.04.27
€21.27
Performance (%)
-7.11%
Price
07:42
€21.82
Summary
This prediction is currently active. With a performance of -7.11%, the SELL prediction by Royal_Bank_of_Canada is trending in the right direction. This prediction currently runs until 20.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 0.069% | 0.069% |
| iShares Core DAX® | 2.992% | 3.220% |
| iShares Nasdaq 100 | -1.584% | -3.172% |
| iShares Nikkei 225® | -2.254% | -9.924% |
| iShares S&P 500 | -0.009% | 1.641% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (PFE) had its "underperform" rating reaffirmed by Royal Bank Of Canada. They now have a $25.00 price target on the stock.
Ratings data for PFE provided by MarketBeat

